SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-456184
Filing Date
2014-12-30
Accepted
2014-12-30 07:12:59
Documents
3
Period of Report
2014-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d842552d8k.htm 8-K 17693
2 EX-99.1 d842552dex991.htm EX-99.1 11137
3 GRAPHIC g842552g02m71.jpg GRAPHIC 13685
  Complete submission text file 0001193125-14-456184.txt   49088
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 141314468
SIC: 2835 In Vitro & In Vivo Diagnostic Substances